AstraZeneca starts final-stage tests on severe asthma drug – Reuters


Reuters UK

AstraZeneca starts final-stage tests on severe asthma drug
Reuters
Several firms are racing to develop injectable biotech asthma drugs for patients with severe disease who do not respond well to traditional inhalers, in pursuit of a new market worth a possible $7.5 billion a year. (Reporting by Ben Hirschler, Editing
AstraZeneca Starts Phase III Trial For Asthma Drug TralokinumabLondon South East
AstraZeneca Starts Late-stage Study Of Tralokinumab – Quick FactsRTT News

all 4 news articles »

View full post on asthma – Google News

GlaxoSmithKline starts final-stage tests on severe asthma drug – Fox News

GlaxoSmithKline starts final-stage tests on severe asthma drug
Fox News
Severe refractory asthma only affects around 4 percent of patients with the disease, so the drug may not become a major seller for GSK but could consolidate the group's strong grip on the market for lung drugs. Print; Email; Share; Comments; Recommend
GSK Begins Phase lll Program for Mepolizumab in Severe Refractory AsthmaFox Business
GSK starts final-stage tests on severe asthma drugWHTC

all 14 news articles »

View full post on asthma – Google News

GSK starts final-stage tests on severe asthma drug – Reuters

GSK starts final-stage tests on severe asthma drug
Reuters
Severe refractory asthma only affects around 4 percent of patients with the disease, so the drug may not become a major seller for GSK but could consolidate the group's strong grip on the market for lung drugs. (Reporting by Ben Hirschler). Health
GSK Begins Phase lll Program for Mepolizumab in Severe Refractory Asthma4-traders

all 5 news articles »

View full post on asthma – Google News